| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |